Not Tagged
Not Tagged
['lung', 'nsclc', 'sclc']
a new study in , led by &amp; , suggests that a 2-year immunotherapy duration is reasonable for advanced #lungcancer, and indefinite immunotherapy is not associated with improved survival. #nsclc #asco23 
We are dedicated to the highest standards of patient care, education and research. Please allow up to  24 hours to reply to @ messages. https://t.co/ywUzQ9yGf3